Emerging evidences have indicated that the activation of ferroptosis by GPX4 inhibitors (such as peptide GACNWLPLYPCPV6, derived by screening peptide libraries displayed on T7 phages) is increasingly recognized as a prominent therapeutic strategy for tumor suppression7,8. The gene discussed is GPX4; the disease is neoplasm.